Cellular Dysfunction in Exfoliation Glaucoma
剥脱性青光眼的细胞功能障碍
基本信息
- 批准号:9980044
- 负责人:
- 金额:$ 42.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAge related macular degenerationAgingAlzheimer&aposs DiseaseAmino Acid SequenceAmino AcidsAnteriorAutophagocytosisCell LineCellsCellular Stress ResponseCellular biologyChimera organismChronicCiliary BodyCodeComplexCoupledDangerousnessDataDeacetylaseDefectDependenceDepositionDevelopmentDiseaseElastic FiberEndoplasmic Reticulum Degradation PathwayEnzymesEthnic OriginExfoliation SyndromeExperimental ModelsExtracellular MatrixExtracellular ProteinEyeFibroblastsFunctional disorderGenerationsGeneticGenomicsGlaucomaHDAC6 geneHealthHealth StatusHumanHuntington DiseaseImpairmentIrisLinkLiquid substanceMediatingMicrotubulesMitochondriaMolecularMolecular ChaperonesMorbidity - disease rateNeurodegenerative DisordersOpen-Angle GlaucomaParkinson DiseasePathologyPathway interactionsPatientsPopulationPositioning AttributePrimary Open Angle GlaucomaProcessProtein Export PathwayProtein-Lysine 6-OxidaseProteinsPublishingQuality ControlRiskRoleSkinSourceStretchingStructureSurfaceSystemTestingTissuesTrabecular meshwork structureTrabeculectomyTropoelastinUbiquitinVariantage relatedcell immortalizationcrosslinkexperimental studyhigh riskimprovedin silicolensmisfolded proteinmulticatalytic endopeptidase complexoverexpressionpolypeptidepreservationprotein aggregationproteostasisresponsesulfated glycoprotein 2
项目摘要
Project Summary/Abstract: Cellular Dysfunction in Exfoliation Glaucoma Exfoliation syndrome
(XFS) is an age-related disease involving the deposition of aggregated fibrillar material (XFM) in
extracellular matrices. Its main morbidity is in the eye, where XFM forms on the surface of
anterior segment tissues. XFM causes exfoliation glaucoma (XFG), a rapidly progressing disease
associated with approximately 1/3 of open-angle glaucoma (POAG) cases worldwide. XFG
demonstrates a sharp age-dependence in similarity to the many age-related diseases qualified
as aggregopathies. LOXL1, a matrix cross-linking enzyme that catalyzes the crosslinking of
tropoelastin for the synthesis of elastic fibers and a major component of XFM, has been linked to XFG
by Genomics Wide Association Studies, however, it is still unclear how LOXL1 protein
contributes to disease pathology.Progress in understanding the cellular basis for XFS/G has been
slowed by a lack of experimental models. Working with primary human tenon fibroblasts (TF)
derived from trabeculectomies of XFG patients and controls (age-matched POAG patients and No-
Glaucoma patients), we recently found that, XFG-TFs display many of the functional features
observed in cells from other age-related aggregopathies such as Parkinson's, Alzheimer's, and
AMD including defects in lysosomal positioning, autophagy, microtubule organization and function,
and mitochondrial health status. Linking LOXL1 to the development of XFG, we have found that
XFG-TF a) display increased LOXL1 export by a mechanism aimed at neutralizing misfolded
nascent polypeptides; b) process LOXL1 through autophagy indicating the presence of
misfolded or denatured units of this protein; c) accumulate intracellular protein aggregates with
higher endogenous expression; and d) overexpress clusterin an aggregate-responsive chaperone-
like protein. Finally, an in silico examination of LOXL1 secondary structure indicated that LOXL1
protein has elemental structures within the N-terminus that are predicted to confer an increased
aggregation propensity. Furthermore, experiments of LOXL1 whole protein or with deletions shows
that indeed LOXL1 has high aggregation propensity and that the loci of this propensity reside
within specific stretches of the N-terminus. Accordingly, we seek to answer fundamental
questions on the factors that underpin XFG pathology. We propose, SpA1) to study the molecular
machinery leading to the defects in microtubule function; SpA2) to investigate cellular stress
responses, and the connection between LOXL1 export and misfolded protein machinery, and SpA3)
to identify the minimal amino acid sequences and structural features of the LOXL1 sequence that
mediate its aggregation propensity.
项目摘要/摘要:剥脱性青光眼综合征的细胞功能障碍
(XFS)是一种与年龄相关的疾病,涉及聚集的纤维物质(XFM)在
细胞外基质。它的主要发病是在眼睛,在那里XFM形成在表面
前段组织。XFM导致剥脱性青光眼(XFG),这是一种进展迅速的疾病
与全球约三分之一的开角型青光眼(POAG)病例有关。XFG
表现出强烈的年龄依赖性,与许多符合条件的年龄相关疾病相似
作为聚集性疾病。LOXL1,一种基质交联酶,催化
原弹性蛋白用于合成弹性纤维,是XFM的主要成分,已与XFG联系在一起
然而,通过基因组学广泛关联研究,仍然不清楚LOXL1蛋白是如何
有助于疾病病理。了解XFS/G的细胞基础的进展
由于缺乏实验模型而变得缓慢。与原代人TENON成纤维细胞(TF)合作
来源于XFG患者和对照组的小梁切除术(年龄匹配的POAG患者和非POAG患者)。
青光眼患者),我们最近发现,XFG-TF显示了许多功能特征
在其他年龄相关聚集性疾病的细胞中观察到,如帕金森氏症、阿尔茨海默氏症和
AMD包括溶酶体定位、自噬、微管组织和功能缺陷,
以及线粒体的健康状况。将LOXL1与XFG的开发联系起来,我们发现
Xfg-tf a)显示通过旨在中和错误折叠的机制增加LOXL1出口
新生多肽;b)通过自噬来处理LOXL1,表明存在
错误折叠或变性的蛋白质单位;c)通过以下途径积累细胞内蛋白质聚集体
更高的内源性表达;以及d)过表达聚集反应伴侣中的簇-
像蛋白质一样。最后,对LOXL1二级结构的电子检测表明,LOXL1
蛋白质在N-末端具有基本结构,预计这些结构会增加
聚合倾向。此外,对LOXL1全蛋白或缺失的实验表明
确实,LOXL1具有很高的聚集倾向,并且这种倾向的位置位于
在N端的特定伸展范围内。因此,我们试图从根本上回答
关于支持XFG病理的因素的问题。我们建议,SpA1)来研究分子
导致微管功能缺陷的机制;SpA2)以研究细胞应激
响应,以及LOXL1输出和错误折叠的蛋白质机制之间的联系,以及SpA3)
鉴定LOXL1序列的最小氨基酸序列和结构特征
调节其聚集倾向。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AUDREY M BERNSTEIN其他文献
AUDREY M BERNSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AUDREY M BERNSTEIN', 18)}}的其他基金
A Self-Delivery siRNA for Promoting Regenerative Healing in the Eye
用于促进眼部再生愈合的自我递送 siRNA
- 批准号:
10664929 - 财政年份:2021
- 资助金额:
$ 42.68万 - 项目类别:
A Self-Delivery siRNA for Promoting Regenerative Healing in the Eye
用于促进眼部再生愈合的自我递送 siRNA
- 批准号:
10406147 - 财政年份:2021
- 资助金额:
$ 42.68万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
- 批准号:
10102692 - 财政年份:2024
- 资助金额:
$ 42.68万 - 项目类别:
EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
- 批准号:
10639785 - 财政年份:2023
- 资助金额:
$ 42.68万 - 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
- 批准号:
23K09052 - 财政年份:2023
- 资助金额:
$ 42.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 42.68万 - 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
- 批准号:
10642988 - 财政年份:2023
- 资助金额:
$ 42.68万 - 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 42.68万 - 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
- 批准号:
10584110 - 财政年份:2023
- 资助金额:
$ 42.68万 - 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
- 批准号:
22H03243 - 财政年份:2022
- 资助金额:
$ 42.68万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
- 批准号:
10433610 - 财政年份:2022
- 资助金额:
$ 42.68万 - 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
- 批准号:
10504138 - 财政年份:2022
- 资助金额:
$ 42.68万 - 项目类别:














{{item.name}}会员




